A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemia

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Anthracyclines are effective in the treatment of leukemia, but their use is limited because of cardiotoxicity. Liposomal daunorubicin (L-DNR) is potentially less cardiotoxic than daunorubicin (DNR). We compared in vitro cytotoxicity in pediatric acute leukemia samples and found no significant differences between cytotoxicity of DNR and L-DNR.

Original languageEnglish
Pages (from-to)1573-1574
Number of pages2
JournalHaematologica
Volume91
Issue number11
Publication statusPublished - Nov 2006
Externally publishedYes

Keywords

  • Cardiotoxicity
  • Drug sensitivity
  • Liposomal daunombicin
  • Pediatric acute leukemia

Fingerprint

Dive into the research topics of 'A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemia'. Together they form a unique fingerprint.

Cite this